# MCO Membrane Efficiency in Septic Shock Patients

> **NCT04834921** · NA · COMPLETED · sponsor: **Fiorenza Ferrari** · enrollment: 20 (actual)

## Conditions studied

- Septic Shock
- Acute Kidney Injury

## Interventions

- **DEVICE:** Ultraflux® EMiC®2

## Key facts

- **NCT ID:** NCT04834921
- **Lead sponsor:** Fiorenza Ferrari
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-31
- **Primary completion:** 2020-02-21
- **Final completion:** 2021-01-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-04-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834921, "MCO Membrane Efficiency in Septic Shock Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04834921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*